10x Genomics is trading at $91.39, down 6.50%, with no fresh company-specific announcement explaining the decline.
- The latest company news found was September 29 product announcements about Sentira and Atera.
- Biotech shares are weak, with the XBI down 2.50% during the session.
- Major U.S. indexes are higher, so broad-market weakness does not explain the move.